| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $1.6B | $0.8B | $0.6B | $0.4B | $0.1B | $0.1B | $0.1B |
| Cost of Revenue | $0.0B | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.4B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.43 | $6.37 | $3.50 | $3.56 | $2.45 | — | — | — |
| EPS (Diluted) | $1.40 | $6.33 | $3.45 | $3.56 | $2.45 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.9B | $8.3B | $5.1B | $2.9B | $2.0B | $0.5B | $0.4B | $0.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.8B | $0.5B | $0.6B | $0.6B | $0.7B | $0.1B | $0.0B | $0.1B |
| Total Liabilities | $8.7B | $7.1B | $4.3B | $2.4B | $1.7B | $0.3B | $0.2B | $0.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.2B | $1.2B | $0.8B | $0.5B | $0.3B | $0.1B | $0.1B | $0.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $-1.1B | $-1.0B | $-0.3B | $0.6B | — | — | — |
| Investing Cash Flow | $-0.9B | $-0.6B | $-1.5B | $-0.0B | $0.1B | — | — | — |
| Capital Expenditures | — | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $1.7B | $2.1B | $0.5B | $0.3B | — | — | — |